-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$27.3321.63% Upside
BioLife Solutions, Inc. Frequently Asked Questions
-
What analysts cover BioLife Solutions, Inc.?
BioLife Solutions, Inc. has been rated by research analysts at Stephens, Craig-Hallum, Jefferies in the past 90 days.